Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

5.7K
5.7K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

705
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
705
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

59
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
59

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anemia and leukopenia following intravenous colloidal silver infusions-Clinical and hematological features, unique peripheral blood film appearance and effective therapy with supplemental oral copper and apheresis.

Clinical case reports·2019
Same author

Incidence of chemotherapy-induced peripheral neuropathy within 12 weeks of starting neurotoxic chemotherapy for multiple myeloma or lymphoma: a prospective, single-center, observational study.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2019
Same author

Delayed autologous stem cell transplantation following cardiac transplantation experience in patients with cardiac amyloidosis.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2019
Same author

Use of an Intravascular Warming Catheter during Off-Pump Coronary Artery Bypass Surgery in a Patient with Severe Cold Hemagglutinin Disease.

Texas Heart Institute journal·2016
Same author

Diffuse Large B-Cell Lymphoma Presenting as a Cardiac Mass.

Texas Heart Institute journal·2016
Same author

Amyloidosis: changing approaches and outcomes.

Methodist DeBakey cardiovascular journal·2012

Related Experiment Video

Updated: Sep 27, 2025

Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging
10:04

Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging

Published on: October 20, 2017

13.6K

Light Chain Amyloidosis: Epidemiology, Staging, and Prognostication.

Kelty R Baker1

  • 1Houston Methodist Hospital, Houston, Texas, US.

Methodist Debakey Cardiovascular Journal
|April 13, 2022
PubMed
Summary

Amyloidosis involves protein misfolding, leading to fibril deposition and organ damage. This review focuses on light chain amyloidosis epidemiology, staging, and prognostication for treatment guidance.

Keywords:
Mayo Clinic staging systemcardiac amyloidosislight chain amyloidosisprognosis

More Related Videos

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
06:33

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

Published on: June 9, 2018

7.8K
Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

21.5K

Related Experiment Videos

Last Updated: Sep 27, 2025

Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging
10:04

Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging

Published on: October 20, 2017

13.6K
Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
06:33

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

Published on: June 9, 2018

7.8K
Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

21.5K

Area of Science:

  • Biochemistry
  • Pathology
  • Genetics

Background:

  • Amyloidosis is a protein misfolding disease characterized by insoluble fibril deposition in tissues.
  • Over 30 identified amyloidogenic proteins can cause human diseases.
  • These proteins form beta-pleated sheets, creating rigid fibrils that resist degradation and cause organ dysfunction.

Purpose of the Study:

  • To review the epidemiology of light chain amyloidosis (AL).
  • To discuss staging systems for AL.
  • To highlight the importance of prognostication in guiding AL treatment.

Main Methods:

  • Literature review of amyloidosis, focusing on AL.
  • Analysis of epidemiological data for AL.
  • Examination of current staging and prognostication methods relevant to AL.

Main Results:

  • Amyloidosis affects multiple organs, including the heart, kidneys, and nervous system.
  • Specific protein misfolding patterns, particularly beta-pleated sheets, are central to fibril formation.
  • Epidemiological data, staging, and prognostication are crucial for effective AL management.

Conclusions:

  • Understanding amyloidosis pathogenesis is key to addressing organ dysfunction.
  • Light chain amyloidosis requires specific epidemiological insights for targeted interventions.
  • Accurate staging and prognostication are essential for optimizing treatment strategies in AL.